1. Home
  2. EVER vs BBNX Comparison

EVER vs BBNX Comparison

Compare EVER & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

HOLD

Current Price

$17.67

Market Cap

571.6M

Sector

Technology

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$12.47

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVER
BBNX
Founded
2008
2015
Country
United States
United States
Employees
N/A
423
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
571.6M
493.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
EVER
BBNX
Price
$17.67
$12.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$27.00
$23.80
AVG Volume (30 Days)
770.5K
684.5K
Earning Date
05-04-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
198.86
N/A
EPS
0.51
N/A
Revenue
$163,349,000.00
N/A
Revenue This Year
$14.73
$34.90
Revenue Next Year
$11.51
$34.63
P/E Ratio
$35.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.88
$8.80
52 Week High
$28.73
$32.71

Technical Indicators

Market Signals
Indicator
EVER
BBNX
Relative Strength Index (RSI) 46.10 63.65
Support Level $17.25 $9.34
Resistance Level $26.33 $13.35
Average True Range (ATR) 1.06 0.76
MACD -0.14 0.30
Stochastic Oscillator 11.99 84.68

Price Performance

Historical Comparison
EVER
BBNX

About EVER EverQuote Inc.

EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: